Syn-Xtract™
Cell-free lysates
We are the experts in Cell-Free technology.

E. coli Cell-Free Lysates:
Take advantage of Synthelis’ proprietary technology with this reagent containing T7 RNA polymerase, enabling protein production under a T7 promoter. Simply add your reaction mix and DNA to synthesize your protein of interest.
350 μL
145 €
5 x 350 μL
510 €
Application domains

Domaine
Biomedicines

Domaine
Synthetic biology

Domaine
Bioproduction

Domaine
Structural biology

Domaine
Bioeconomy

Domaine
Point-of-care bioproduction
Application notes
Validation of a phage library-based panning strategy for the selection of specific anti-C5aR monoclonal antibodies
Label-free Kinetic Analysis of Membrane Protein Interactions Using Biolayer Interferometry (BLI)
Validation of a new method to characterize proteoliposome in solution by force spectroscopy with atomic force microscopy
Successful production of antibodies against functional GPCR : Case study using functional CXCR4-containing liposomes
Our customers talk about it
"We worked with the Synthelis team for two years on a large-scale project for cell-free protein synthesis. In addition to their perfect knowledge of protein synthesis in different conditions, quantification & validation, the team is fully dedicated to our project, working with flexibility and perfect communication."
Laurent CHENE
"Synthelis team was very efficient to provide us with a solution to our persistent inclusion body issue. We believe that the cell-free could be a promising alternative expression system to overcome some bottlenecks."
Nicolas CHAUDET
"Synthelis' team was efficient and professional in providing us with a solution for the rapid development of a biological reagent for coagulation diagnosis. Synthelis' cell-free technology is particularly effective in producing large quantities of complex membrane proteins. What makes the difference in working with Synthelis is their expertise in their technology and their professionalism. I can recommend working with Synthelis because their team and their technology allow to accelerate project development."
Vincent POHER
"At Twist Biopharma, we were looking for a supplier to produce membrane proteins as GPCRs to perform our phage display campaigns. Synthelis took our specifications for this project into consideration, adapted its cell-free expression technology, and supplied us with a challenging receptor in a very short timeline. The quality of the supplied target enabled us to successfully select antagonist and agonist VHH binders confirmed in our bioassays. We are fully satisfied with our collaboration with Synthelis."
Aaron SATO
Other products that may interest you
Our biodesigners
help you
to familiarize yourself
with our system
If you encounter implementation difficulties, we will be able to accompany you.
Need a quote
or a specific
request?
Even
a protein
needs
to express
its potential.
Cell-Free Systems Applications